Search

Your search keyword '"Gurm, Hitinder S."' showing total 76 results

Search Constraints

Start Over You searched for: Author "Gurm, Hitinder S." Remove constraint Author: "Gurm, Hitinder S." Topic myocardial infarction Remove constraint Topic: myocardial infarction
76 results on '"Gurm, Hitinder S."'

Search Results

2. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.

4. Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan.

5. Door to Balloon Time: Is There a Point That Is Too Short?

6. Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States.

7. Underutilization of Radial Access in Patients Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

8. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.

9. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry.

12. Door-to-balloon time and mortality.

13. Door-to-balloon time and mortality among patients undergoing primary PCI.

14. False activation of the cardiac catheterization laboratory for primary PCI.

15. The ongoing importance of smoking as a powerful risk factor for ST-segment elevation myocardial infarction in young patients.

16. Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

17. Eroding the denominator: the incomplete story of door-to-balloon time reporting.

19. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

20. Treatment and outcomes of first troponin-negative non-ST-segment elevation myocardial infarction.

21. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

22. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

23. Fragmented QRS complex has poor sensitivity in detecting myocardial scar.

24. Anticoagulation during percutaneous coronary intervention in diabetics--is simpler always better?

25. Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials.

26. A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.

27. We were fishing for TROUT and we caught a CARP: musings on perioperative management in an age of enlightenment.

28. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction.

29. Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.

30. GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: new trial and registry data.

31. The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention.

32. Use of anticoagulants in ST-segment elevation myocardial infarction patients; a focus on low-molecular-weight heparin.

33. Dual antiplatelet agent failure: a new syndrome or clinical nonentity?

34. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

35. Recent trends in hospital utilization for acute myocardial infarction and coronary revascularization in the United States.

36. Impact of diabetes mellitus on outcome of patients undergoing carotid artery stenting: insights from a single center registry.

37. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.

38. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting.

39. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.

40. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.

41. In-Hospital Death Among Patients Undergoing Percutaneous Coronary Intervention: A Root-Cause Analysis.

42. Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States.

43. Fragmented QRS Complex Has Poor Sensitivity in Detecting Myocardial Scar

44. The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

45. The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC.

46. Comparison of Acute Coronary Syndrome in Patients Receiving Versus Not Receiving Chronic Dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry)

47. Safety of Contemporary Percutaneous Peripheral Arterial Interventions in the Elderly: Insights From the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) Registry.

48. Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes, and Predictors of Mortality: A Report From the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry.

49. Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis.

50. Safety and efficacy of thrombectomy in patientsundergoing primary percutaneous coronaryintervention for Acute ST elevation MI: AMeta-Analysis of Randomized Controlled Trials.

Catalog

Books, media, physical & digital resources